Cargando…

Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19

The coronavirus disease 2019 (COVID-19) global pandemic continues and antiviral agents and vaccines are currently under investigation. Mesenchymal stem cell (MSC)-based therapy can be a suitable option for management of patients with COVID-19 at the urgent time of virus outbreak. Currently, MSCs are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chenghai, Zhao, Hua, Wang, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533900/ https://www.ncbi.nlm.nih.gov/pubmed/33061304 http://dx.doi.org/10.2147/DDDT.S269407

Ejemplares similares

Mesenchymal stem cells as a potential therapy for COVID-19
por: Liu, Shan, et al.
Publicado: (2020)

Mesenchymal stem cells in the treatment of severe COVID-19
por: Kesari, Santosh, et al.
Publicado: (2021)

Mesenchymal stem/stromal cells: Developmental origin, tumorigenesis and translational cancer therapeutics
por: Li, Chenghai, et al.
Publicado: (2020)

Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice
por: Li, Chenghai, et al.
Publicado: (2021)

Pre-conditioned mesenchymal stem cells: a better way for cell-based therapy
por: Li, Qing, et al.
Publicado: (2013)

Encapsulation of Mesenchymal Stem Cells: Dissecting the Underlying Mechanism of Mesenchymal Stem Cell Transplantation Therapy
por: Kin, Kyohei, et al.
Publicado: (2020)

Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction
por: Safari, Anahid, et al.
Publicado: (2021)

Combating COVID-19 With Mesenchymal Stem/Stromal Cell Therapy: Promise and Challenges
por: Wang, Shihua H., et al.
Publicado: (2021)

Mesenchymal Stem/Stromal Cells in Progressive Fibrogenic Involvement and Anti-Fibrosis Therapeutic Properties
por: Li, Chenghai, et al.
Publicado: (2022)

Among mesenchymal stem cells: for the best therapy after ischemic stroke
por: Ikegame, Yuka
Publicado: (2013)

Mesenchymal Stem Cells for Coronavirus (COVID-19)-Induced Pneumonia: Revisiting the Paracrine Hypothesis with New Hopes?
por: Öztürk, Selçuk, et al.
Publicado: (2020)

Challenges in stem cell-derived islet replacement therapy can be overcome
por: Abdulreda, Midhat H., et al.
Publicado: (2021)

Mesenchymal Stem Cells for the Treatment of Diabetes
por: Pileggi, Antonello
Publicado: (2012)

Mesenchymal Stem Cells & Endothelial Function
por: Fish, Kenneth M., et al.
Publicado: (2015)

Mesenchymal Stem Cells: The Past, the Present, the Future
por: Caplan, Arnold I.
Publicado: (2010)

Transition of mesenchymal stem/stromal cells to endothelial cells
por: Crisan, Mihaela
Publicado: (2013)

Commentary: Mending a broken heart: The ongoing quest for mesenchymal stem cell therapy for ischemic cardiomyopathy
por: Spinetti, Gaia, et al.
Publicado: (2021)

The dual role of mesenchymal stem cells in tumor progression
por: Gomes, Célia Maria Freitas
Publicado: (2013)

Aging of mesenchymal stem cells: Implication in regenerative medicine
por: Yang, Yueh-Hsun Kevin
Publicado: (2018)

Mesenchymal Stem Cell-Based Therapy for Stroke: Current Understanding and Challenges
por: Li, Weifeng, et al.
Publicado: (2021)

Mesenchymal stem cell therapy for severe COVID-19
por: Shi, Lei, et al.
Publicado: (2021)

Commentary about mesenchymal stem cells and scarred vocal folds
por: Mattei, Alexia, et al.
Publicado: (2020)

Mesenchymal stem cells of dental origin as promising tools for neuroregeneration
por: Varga, Gábor, et al.
Publicado: (2014)

Influencing the secretion of myogenic factors from mesenchymal stem cells
por: Smith, Lucas R
Publicado: (2014)

Mesenchymal stem cells immunosuppressive properties: is it specific to bone marrow-derived cells?
por: Jorgensen, Christian
Publicado: (2010)

Aging as an essential modifier for the efficacy in mesenchymal stem cell therapy through an inositol phosphate 6 kinase-inositol pyrophosphate 7-dependent mechanism
por: Wang, Sherry Shuyi, et al.
Publicado: (2014)

Iron-dependent cell death as executioner of cancer stem cells
por: Zhao, Bin, et al.
Publicado: (2018)

Challenges in the clinical application of induced pluripotent stem cells
por: Sipp, Douglas
Publicado: (2010)

Mesenchymal Stem Cells: A Potential Border Patrol for Transplanted Islets?
por: Brusko, Todd M.
Publicado: (2009)

Bone marrow mesenchymal stem cells and liver regeneration: believe the hypoxia!
por: Garg, Abhilok, et al.
Publicado: (2013)

Biological effects of cancer-secreted factors on human mesenchymal stem cells
por: Lam, Paula YP
Publicado: (2013)

Periodic Heat Shock Accelerated the Chondrogenic Differentiation of Human Mesenchymal Stem Cells in Pellet Culture
por: Chen, Jing, et al.
Publicado: (2014)

Stem cell-based therapy for α(1)-antitrypsin deficiency
por: Rashid, S Tamir, et al.
Publicado: (2012)

Challenges and Controversies to Testing for COVID-19
por: Binnicker, Matthew J.
Publicado: (2020)

The challenges of distributing COVID-19 vaccinations
por: Mills, Melinda C., et al.
Publicado: (2020)

Transplantation of Mesenchymal Stem Cells: A Potential Adjuvant Therapy for COVID-19
por: Zhu, Yingqian, et al.
Publicado: (2020)

Mesenchymal stromal cells and leukemia therapy in mice and man
por: Gale, Robert Peter
Publicado: (2020)

Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives
por: Karakaş, Nihal, et al.
Publicado: (2022)

The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy
por: Zhang, Jun, et al.
Publicado: (2015)

PGC-1α: The Missing Ingredient for Mesenchymal Stem Cell–Mediated Angiogenesis
por: Hsueh, Willa A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7l9emha61io35dqnuhbvmjvlha